TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 19 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $91,000 | -46.8% | 14,400 | -42.4% | 0.07% | -59.3% |
| Q3 2014 | $171,000 | -52.4% | 25,000 | 0.0% | 0.17% | -49.4% |
| Q2 2014 | $359,000 | +38.1% | 25,000 | 0.0% | 0.34% | +52.5% |
| Q1 2014 | $260,000 | +58.5% | 25,000 | -44.4% | 0.22% | +24.6% |
| Q3 2013 | $164,000 | – | 45,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 800,000 | $1,592,000 | 1.06% |
| PURA VIDA INVESTMENTS, LLC | 284,877 | $567,000 | 0.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,097,248 | $4,174,000 | 0.23% |
| Broadfin Capital, LLC | 433,911 | $863,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 585,914 | $1,166,000 | 0.06% |
| FNY Managed Accounts LLC | 26,000 | $51,740,000 | 0.05% |
| BLUESTEIN R H & CO LLC | 175,905 | $350,000 | 0.03% |
| FT Options LLC | 15,000 | $30,000 | 0.03% |
| Klingman & Associates, LLC | 10,000 | $20,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 103,900 | $207,000 | 0.00% |